Epirubicin, cisplatin, and raltitrexed in patients with advanced gastric and hepatobiliary carcinoma: A phase II study

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 27, Issue 5, 2004, Pages 445-448

  Ferrari, Vittorio D ^a   Amoroso, Vito ^a   Valcamonico, Francesca ^a   Fusi, Alberto ^a   Simoncini, Edda ^a   Vasalli, Lucia ^a   Rangoni, Giovanni ^a   Mambrini, Andrea ^a   Marpicati, Patrizia ^a   Montini, Elisabetta ^a   Marini, Giovanni ^a,b  

^a Azienda Spedali Civili   (Italy)

^b Oncologia Medica   (Italy)

Author keywords

Chemotherapy; Gastric carcinoma; Hepatobiliary tumors; Raltitrexed

Indexed keywords

CISPLATIN; EPIRUBICIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; RALTITREXED;

ADULT; ADVANCED CANCER; AGED; ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; BILE DUCT CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG ACTIVITY; DRUG FATALITY; DRUG INDICATION; DRUG INFUSION; DRUG RESPONSE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; LIVER CARCINOMA; MALE; METASTASIS; MUCOSA INFLAMMATION; NAUSEA; NEUROTOXICITY; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; STOMACH CARCINOMA; STROKE; SURVIVAL RATE; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILIARY TRACT NEOPLASMS; CISPLATIN; EPIRUBICIN; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; QUINAZOLINES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; THIOPHENES;

EID: 5644295468     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000128722.41587.19     Document Type: Article

References (16)

1. Wils J. The treatment of advanced gastric cancer. Semin Oncol. 1996; 23:397-406.
2. Webb A, Cunningham D, Scarffe H, et al. Randomised trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol. 1997;15:261-267.
3. National Comprehensive Cancer Network. NCCN practice guidelines for upper gastrointestinal carcinomas. Oncology (Huntingt) 1999;12:179-223.
4. Sciarrino E, Simonetti RG, Moli SL, et al. Adriamycin treatment for hepatocellular carcinoma. Cancer. 1985;56:2751-2755.
5. Falkson G, MacIntyre JM, Moertel CG. Co-operative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer. 1984;54:965-969.
6. Ellis PA, Norman A, Hill A, et al. Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours. Eur J Cancer. 1995;10:1594-1598.
7. Ducreux M, Rougier P, Fandi A, et al. Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann Oncol. 1998;9:653-656.
8. Cocconi G, Cunningham D, Van Cutsem E, et al. Open, randomized, multicentre trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. J Clin Oncol. 1998; 16:2943-2952.
9. Maughan TS, James RD, Kerr DJ, et al. Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. Lancet. 2002;359:1555-1563.
10. Pazdur R, Meropol NJ, Camper ES, et al. Phase II trial of ZD 1694 (Tomudex) in patients with advanced pancreatic cancer. Invest New Drugs. 1996;13:355-358.
11. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer. 1981;47:201-214.
12. Mackay HJ, McInnes A, Paul J, et al. A phase II study of epirubicin, cisplatin and raltitrexed combination chemotherapy (ECT), in patients with advanced oesophageal and gastric adenocarcinoma. Ann Oncol. 2001;12:1407-1410.
13. Eatock MM, Anthony DA, El-Abassi M, et al. A dose-finding study of raltitrexed (Tomudex) with cisplatin and epirubicin in advanced gastrooesophageal adenocarcinoma. Br J Cancer. 2000;82:1925-1931.
14. Zaniboni A, Barni S, Labianca R, et al. Epirubicin, cisplatin and continuous infusion 5-fluorouracil is an active and safe regimen for patients with advanced gastric cancer. Cancer. 1995;76:1694-1699.
15. Cascinu S, Labianca R, Alessandroni P, et al. Intensive weekly chemotherapy for advanced gastric cancer using fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathione, and filgastrim: a report from the Italian Group for the Study of Digestive Tract Cancer. J Clin Oncol. 1997;15:3313-3319.
16. Tebbutt N, Norman A, Cunningham D, et al. Randomised, multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophago-gastric cancer; interim analysis. Proc Am Soc Clin Oncol. 2002;21:523a.